The 'heightmaxxing' trend is pushing some teenagers towards erdafitinib, a prescription cancer drug, in the hope of growing taller. But research cited by users involved only two children undergoing cancer treatment, and the medicine is not approved for height enhancement. Local authorities and relevant stakeholders are closely monitoring the situation as fresh developments unfold on the ground.